Vishal Dhruva1, Christy Lawson2, Caitlin Green3, Carolyn Newberry4. 1. Rutgers New Jersey Medical School, 65 Bergen Street, Newark, NJ, 07103, USA. 2. Division of Trauma and Critical Care Surgery, University of Tennessee Medical Center, 1932 Alcoa Hwy Ste 270, Knoxville, TN, 37920, USA. 3. Division of Gastroenterology, Medical University of South Carolina, 1600 Midtown Avenue, Mount Pleasant, SC, 29464, USA. 4. Division of Gastroenterology, Weill Cornell Medical Center, 445 East 69th Street, 4th Floor, New York, NY, 10021, USA. can9054@med.cornell.edu.
Abstract
PURPOSE OF REVIEW: Celiac disease (CD) is a prevalent digestive illness as well as a budding area of research in the field of gastroenterology. While investigations are underway to find new and improved pharmacological therapies for CD, the gluten-free diet (GFD) remains the only option to effectively manage the condition. RECENT FINDINGS: While the GFD is recommended for patients diagnosed with CD and other gluten-related conditions, studies show the number of individuals on the GFD surpasses the projected number of patients with these medical indications (1). The implications of widespread adoption of this dietary approach are still being determined, with many patients believing this diet will improve overall health and cardiovascular risk. This review analyzes the relationship between a GFD and metabolic syndrome in both non-celiac and celiac patients, concluding that although the diet may slightly improve overall cardiac risk factors, weight, and/or insulin resistance, its use in the absence of a gluten-related disorder is controversial.
PURPOSE OF REVIEW: Celiac disease (CD) is a prevalent digestive illness as well as a budding area of research in the field of gastroenterology. While investigations are underway to find new and improved pharmacological therapies for CD, the gluten-free diet (GFD) remains the only option to effectively manage the condition. RECENT FINDINGS: While the GFD is recommended for patients diagnosed with CD and other gluten-related conditions, studies show the number of individuals on the GFD surpasses the projected number of patients with these medical indications (1). The implications of widespread adoption of this dietary approach are still being determined, with many patients believing this diet will improve overall health and cardiovascular risk. This review analyzes the relationship between a GFD and metabolic syndrome in both non-celiac and celiac patients, concluding that although the diet may slightly improve overall cardiac risk factors, weight, and/or insulin resistance, its use in the absence of a gluten-related disorder is controversial.
Authors: M Barone; N Della Valle; R Rosania; A Facciorusso; A Trotta; F P Cantatore; S Falco; S Pignatiello; M T Viggiani; A Amoruso; R De Filippis; A Di Leo; R Francavilla Journal: Eur J Clin Nutr Date: 2015-07-15 Impact factor: 4.016
Authors: Katherine V Williams; Christina L Cristaldi; Rachel G Miller; Vincent C Arena; Ingrid Libman; Yihe Huang; Dorothy J Becker; Trevor J Orchard Journal: J Clin Endocrinol Metab Date: 2018-10-01 Impact factor: 5.958
Authors: Geng Zong; Benjamin Lebwohl; Frank B Hu; Laura Sampson; Lauren W Dougherty; Walter C Willett; Andrew T Chan; Qi Sun Journal: Diabetologia Date: 2018-08-03 Impact factor: 10.122
Authors: Anna Tavakkoli; Suzanne K Lewis; Christina A Tennyson; Benjamin Lebwohl; Peter H R Green Journal: Dig Dis Sci Date: 2013-12-28 Impact factor: 3.199